522 related articles for article (PubMed ID: 25364765)
21. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
23. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.
Ostadrahimi S; Fayaz S; Parvizhamidi M; Abedi-Valugerdi M; Hassan M; Kadivar M; Teimoori-Toolabi L; Asgari M; Shahrokh H; Abolhasani M; Mahdian R; Fard-Esfahani P
Oncol Lett; 2018 May; 15(5):8157-8164. PubMed ID: 29849810
[TBL] [Abstract][Full Text] [Related]
25. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
26. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
Wu D; Talbot CC; Liu Q; Jing ZC; Damico RL; Tuder R; Barnes KC; Hassoun PM; Gao L
J Mol Med (Berl); 2016 Aug; 94(8):875-85. PubMed ID: 27188753
[TBL] [Abstract][Full Text] [Related]
27. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
29. Role of microRNA-129 in cancer and non-cancerous diseases (Review).
Deng B; Tang X; Wang Y
Exp Ther Med; 2021 Sep; 22(3):918. PubMed ID: 34335879
[TBL] [Abstract][Full Text] [Related]
30. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
32. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
34. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
[TBL] [Abstract][Full Text] [Related]
36. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
37. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
[TBL] [Abstract][Full Text] [Related]
38. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
40. Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
Wang A; Kwee LC; Grass E; Neely ML; Gregory SG; Fox KAA; Armstrong PW; White HD; Ohman EM; Roe MT; Shah SH; Chan MY
Atherosclerosis; 2017 Jun; 261():19-25. PubMed ID: 28437675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
